IgG subclass antibodies to three variants of Plasmodium falciparum merozoite surface protein-1 (PfMSP-119) in an area with unstable malaria transmission in Iran

Acta Tropica

Volumn 119, Issue 2-3, 2011, Pages 84-90

  Mehrizi, Akram Abouie ^a,b   Asgharpour, Sara ^a,c   Salmanian, Ali Hatef ^b   Djadid, Navid Dinparast ^a   Zakeri, Sedigheh ^a  

^a PASTEUR INSTITUTE OF IRAN   (Iran)

^b NATIONAL INSTITUTE OF GENETIC ENGINEERING AND BIOTECHNOLOGY   (Iran)

^c Khatam University   (Iran)

Author keywords

Antibody; E KNG F; E TSG L; Merozoite surface protein 1; Plasmodium falciparum; Q KNG L

Indexed keywords

IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN G1 ANTIBODY; IMMUNOGLOBULIN G2 ANTIBODY; IMMUNOGLOBULIN G3 ANTIBODY; IMMUNOGLOBULIN G4 ANTIBODY; MEROZOITE SURFACE PROTEIN 1; UNCLASSIFIED DRUG;

ANTIBODY; DISEASE TRANSMISSION; IMMUNITY; MORBIDITY; MORTALITY; PROTEIN; PUBLIC HEALTH; VACCINATION;

ADOLESCENT; ADULT; AGED; ANTIBODY AFFINITY; ANTIBODY RESPONSE; ANTIBODY TITER; ANTIGEN BINDING; ARTICLE; CHILD; DISEASE TRANSMISSION; ENZYME LINKED IMMUNOSORBENT ASSAY; ESCHERICHIA COLI; EXPRESSION VECTOR; FEMALE; GROUPS BY AGE; HUMAN; IRAN; MAJOR CLINICAL STUDY; MALARIA; MALARIA FALCIPARUM; MALE; PASSIVE IMMUNIZATION; PLASMODIUM FALCIPARUM; PLASMODIUM VIVAX MALARIA; PROTEIN EXPRESSION; PROTEIN VARIANT;

ADOLESCENT; ADULT; AGED; ANTIBODIES, PROTOZOAN; ANTIBODY AFFINITY; CHILD; CHILD, PRESCHOOL; ESCHERICHIA COLI; FEMALE; HUMANS; IMMUNOGLOBULIN G; IRAN; MALARIA, FALCIPARUM; MALE; MEROZOITE SURFACE PROTEIN 1; MIDDLE AGED; PLASMODIUM FALCIPARUM; RECOMBINANT PROTEINS; SEROEPIDEMIOLOGIC STUDIES; YOUNG ADULT;

IRAN;

ESCHERICHIA COLI; PLASMODIUM FALCIPARUM;

EID: 79960601121     PISSN: 0001706X     EISSN: 18736254     Source Type: Journal    
DOI: 10.1016/j.actatropica.2011.04.012     Document Type: Article

References (51)

1. Al-Yaman F., Genton B., Kramer K.J., Chang S.P., Hui G.S., Baisor M., Alpers M.P. Assessment of the role of naturally acquired antibody levels to Plasmodium falciparum merozoite surface protein 1 in protecting Papua New Guinean children from malaria morbidity. Am. J. Trop. Med. Hyg. 1996, 54:443-448.
2. Blackman M.J., Heidrich H.G., Donachie S., McBride J.S., Holder A.A. A single fragment of malaria merozoite surface protein remains on the parasite during red cell invasion and is the target of invasion-inhibiting antibodies. J. Exp. Med. 1990, 172:379-382.
3. Blackman M.J., Ling I.T., Nicholls S.C., Holder A.A. Proteolytic processing of the Plasmodium falciparum merozoite surface protein-1 produces a membrane-bound fragment containing two epidermal growth factor-like domains. Mol. Biochem. Parasitol. 1991, 49:29-33.
4. Braga E.M., Barros R.M., Reis T.A., Fontes C.J., Morais C.G., Martins M.S., Krettli A.U. Association of the IgG response to Plasmodium falciparum merozoite protein (C-terminal 19kDa) with clinical immunity to malaria in the Brazilian Amazon region. Am. J. Trop. Med. Hyg. 2002, 66:461-466.
5. Camargo L.M., dal Colletto G.M., Ferreira M.U., Gurgel Sde M., Escobar A.L., Marques A., Krieger H., Camargo E.P., da Silva L.H. Hypoendemic malaria in Rondonia (Brazil, western Amazon region): seasonal variation and risk groups in an urban locality. Am. J. Trop. Med. Hyg. 1996, 55:32-38.
6. Camargo L.M., Ferreira M.U., Krieger H., De Camargo E.P., Da Silva L.P. Unstable hypoendemic malaria in Rondonia (Western Amazon Region, Brazil): epidemic outbreaks and work-associated incidence in an agro-industrial rural settlement. Am. J. Trop. Med. Hyg. 1994, 51:16-25.
7. Chang S.P., Gibson H.L., Lee-Ng C.T., Barr P.J., Hui G.S. A carboxyl-terminal fragment of Plasmodium falciparum gp195 expressed by a recombinant baculovirus induces antibodies that completely inhibit parasite growth. J. Immunol. 1992, 149:548-555.
8. Chappel J.A., Holder A.A. Monoclonal antibodies that inhibit Plasmodium falciparum invasion in vitro recognize the first growth factor-like domain of merozoite surface protein-1. Mol. Biochem. Parasitol. 1993, 60:303-311.
9. Cohen S., McGregor I.A., Carrington S. Gamma-globulin and acquired immunity to human malaria. Nature 1961, 192:733-737.
10. Cooper J.A., Cooper L.T., Saul A.J. Mapping of the region predominantly recognized by antibodies to the Plasmodium falciparum merozoite surface antigen MSA1. Mol. Biochem. Parasitol. 1992, 51:301-312.
11. Da Silveira L.A., Ribeiro W.L., Kirchgatter K., Wunderlich G., Matsuoka H., Tanabe K., Ferreira M.U. Sequence diversity and linkage disequilibrium within the merozoite surface protein-1 (Msp-1) locus of Plasmodium falciparum: a longitudinal study in Brazil. J. Eukaryot. Microbiol. 2001, 48:433-439.
12. Diallo T.O., Spiegel A., Diouf A., Lochouarn L., Kaslow D.C., Tall.F A., PerrautF R., Garraud O. Short report: differential evolution of immunoglobulin G1/G3 antibody responses to Plasmodium falciparum MSP1 (19) over time in malaria-immune adult Senegalese patients. Am. J. Trop. Med. Hyg. 2002, 66:137-139.
13. Egan A.F., Chappel J.A., Burghaus P.A., Morris J.S., McBride J.S., Holder A.A., Kaslow D.C., Riley E.M. Serum Antibodies from malaria-exposed people recognize conserved epitopes formed by the two epidermal growth factor motifs of MSP1(19), the carboxyl-terminal fragment of the major merozoite surface protein of Plasmodium falciparum. Infect. Immun. 1995, 63:456-466.
14. Egan A.F., Morris J., Barnish G., Allen S., Greenwood B.M., Kaslow D.C., Holder A.A., Riley E.M. Clinical immunity to Plasmodium falciparum malaria is associated with serum antibodies to the 19-kDa C-terminal fragment of the merozoite surface antigen, PfMSP-1. J. Infect. Dis. 1996, 173:765-769.
15. Escalante A.A., Lal A.A., Ayala F.J. Genetic polymorphism and natural selection in the malaria parasite Plasmodium falciparum. Genetics 1998, 149:189-202.
16. Ferreira M.U., Kimura E.A., De Souza J.M., Katzin A.M. The isotype composition and avidity of naturally acquired anti-Plasmodium falciparum antibodies: differential patterns in clinically immune Africans and Amazonian patients. Am. J. Trop. Med. Hyg. 1996, 55:315-323.
17. Hedman K., Lappalainen M., Seppaia I., Makela O. Recent primary Toxoplasma infection indicated by a low-avidity of specific IgG. J. Infect. Dis. 1989, 159:736-740.
18. Holder A.A. Proteins on the surface of the malaria parasite and cell invasion. Parasitology 1994, 108:S5-S18.
19. Hughes M.K., Hughes A.L. Natural selection on plasmodium surface proteins. Mol. Biochem. Parasitol. 1995, 71:99-113.
20. Hui G.S., Hashiro C., Nikaido C., Case S.E., Hashimoto A., Gibson H., Barr P.J., Chang S.P. Immunological cross-reactivity of the C-terminal 42-kilodalton fragment of Plasmodium falciparum merozoite surface protein expressed in baculovirus. Infect. Immun. 1993, 61:3403-3411.
21. Ladeia-Andrade S., Ferreira M.U., Scopel K.K., Braga E.M., Bastos Mda S., Wunderlich G., Coura J.R. Naturally acquired antibodies to merozoite surface protein (MSP)-1(19) and cumulative exposure to Plasmodium falciparum and Plasmodium vivax in remote populations of the Amazon Basin of Brazil. Mem. Inst. Oswaldo Cruz 2007, 102:943-951.
22. Langhorne J., Ndungu F.M., Sponaas A.M., Marsh K. Immunity to malaria: more questions than answers. Nat. Immunol. 2008, 9:1-8.
23. Leoratti F.M., Durlacher R.R., Lacerda M.V., Alecrim M.G., Ferreira A.W., Sanchez M.C., Moraes S.L. Pattern of humoral immune response to Plasmodium falciparum blood stages in individuals presenting different clinical expressions of malaria. Malar. J. 2008, 7:186.
24. Long C.A., Daly T.M. Humoral response to a carboxyl-terminal region of the merozoite surface protein-1 plays a predominant role in controlling blood-stage infection in rodent malaria. J. Immunol. 1995, 155:236-243.
25. Mamillapalli A., Sunil S., Diwan S.S., Sharma S.K., Tyagi P.K., Adak T., Joshi H., Malhotra P. Polymorphism and epitope sharing between the alleles of merozoite surface protein-1 of Plasmodium falciparum among Indian isolates. Malar. J. 2007, 6:95.
26. Marsh K., Snow R.W. Host-parasite interaction and morbidity in malaria endemic areas. Philos. Trans. R. Soc. Lond. B: Biol. Sci. 1997, 352:1385-1394.
27. Mehrizi A.A., Zakeri S., Salmanian A.H., Sanati M.H., Djadid N.D. Plasmodium falciparum: sequence analysis of the gene encoding the C-terminus region of the merozoite surface protein-1, a potential malaria vaccine antigen, in Iranian clinical isolates. Exp. Parasitol. 2008, 118:378-385.
28. Mehrizi A.A., Zakeri S., Salmanian A.H., Sanati M.H., Djadid N.D. IgG subclasses pattern and high-avidity antibody to the C-terminal region of merozoite surface protein 1 of Plasmodium vivax in an unstable hypoendemic region in Iran. Acta Trop. 2009, 112:1-7.
29. Miller L.H., Roberts T., Shahabuddin M., McCutchan T.F. Analysis of sequence diversity in the Plasmodium falciparum merozoite surface protein-1 (MSP-1). Mol. Biochem. Parasitol. 1993, 59:1-14.
30. Nebie I., Diarra A., Ouedraogo A., Soulama I., Bougouma E.C., Tiono A.B., Konate A.T., Chilengi R., Theisen M., Dodoo D., Remarque E., Bosomprah S., Milligan P., Sirima S.B. Humoral responses to Plasmodium falciparum blood-stage antigens and association with incidence of clinical malaria in children living in an area of seasonal malaria transmission in Burkina Faso. West Afr. Infect. Immun. 2008, 76:759-766.
31. Nguer C.M., Diallo T.O., Diouf A., Tall A., Dieye A., Perraut R., Garraud O. Plasmodium falciparum and merozoite surface protein 1-specific antibody isotype balance in immune Senegalese adults. Infect. Immun. 1997, 65:4873-4876.
32. Oaks S.C., Mitchell V.S., Pearson G.W., Carpenter C.J. Malaria: Obstacles and Opportunities 1991, National Academy Press, Washington, D.C.
33. Omosun Y.O., Anumudu C.I., Adoro S., Odaibo A., Sodiende O., Holder A.A., Nwagwu M., Nwuba R.I. Variation in the relationship between anti-MSP-119 antibody response and age in children infected with P. falciparum during the dry and rainy season. Acta Trop. 2005, 95:233-247.
34. Osier F.H., Fegan G., Polley S.D., Murungi L., Verra F., Tetteh K.K., Lowe B., Mwangi T., Bull P.C., Thomas A.W., Cavanagh D.R., McBride J.S., Lanar D.E., Mackinnon M.J., Conway D.J., Marsh K. Breadth and magnitude of antibody responses to multiple Plasmodium falciparum merozoite antigens are associated with protection from clinical malaria. Infect. Immun. 2008, 76:2240-2248.
35. Richie T.L., Saul A. Progress and challenges for malaria vaccines. Nature 2002, 415:694-701.
36. Riley E.M., Allen S.J., Wheeler J.G., Blackman M.J., Bennett S., Takacs B., Schonfeld H.J., Holder A.A., Greenwood B.M. Naturally acquired cellular and humoral immune responses to the major merozoite surface antigen (PfMSP1) of Plasmodium falciparum are associated with reduced malaria morbidity. Parasite Immunol. 1992, 14:321-337.
37. Roost H.P., Bachmann M.F., Haag A., Kalinke U., Pliska V., Hengartner H., Zinkemagel R.M. Early high-affinity neutralizing anti-viral IgG responses without further overall improvements of affinity. Proc. Natl. Acad. Sci. U.S.A. 1995, 92:1257-1261.
38. Sabchareon A., Burnouf T., Ouattara D., Attanath P., Bouharoun-Tayoun H., Chantavanich P., Foucault C., Chongsuphajaisiddhi T., Druilhe P. Parasitologic and clinical human response to immunoglobulin administration in falciparum malaria. Am. J. Trop. Med. Hyg. 1991, 45:297-308.
39. Sachs J., Malaney P. The economic and social burden of malaria. Nature 2002, 415:680-685.
40. Scopel K.K., Fontes C.J., Ferreira M.U., Braga E.M. Plasmodium falciparum: IgG subclass antibody response to merozoite surface protein-1 among Amazonian gold miners, in relation to infection status and disease expression. Exp. Parasitol. 2005, 109:124-134.
41. Scopel K.K., Fontes C.J., Ferreira M.U., Braga E.M. Factors associated with immunoglobulin G subclass polarization in naturally acquired antibodies to Plasmodium falciparum merozoite surface protein-1: a cross-sectional survey in Brazilian Amazonia. Clin. Vaccine Immunol. 2006, 13:810-813.
42. Shi Y.P., Sayed U., Qari S.H., Roberts J.M., Udhayakumar V., Oloo A.J., Hawley W.A., Kaslow D.C., Nahlen B.L., Lal A.A. Natural immune response to the C-terminal 19-kilodalton domain of P. falciparum merozoite surface protein 1. Infect. Immun. 1996, 64:2716-2723.
43. Snounou G., Viriyakosol S., Zhu X.P., Jarra W., Pinheiro L., do Rosario V.E., Thaithong S., Brown K.N. High sensitivity of detection of human malaria parasites by the use of nested polymerase chain reaction. Mol. Biochem. Parasitol. 1993, 61:315-320.
44. Soe S., Theisen M., Roussilhon C., Aye K.S., Druilhe P. Association between protection against clinical malaria and antibodies to merozoite surface antigens in an area of hyperendemicity in Myanmar: complementarily between responses to merozoite surface protein 3 and the 220-kilodalton glutamate-rich protein. Infect. Immun. 2004, 72:247-252.
45. Stanisic D.I., Richards J.S., McCallum F.J., Michon P., King C.L., Schoepflin S., Gilson P.R., Murphy V.J., Anders R.F., Mueller I., Beeson J.G. Immunoglobulin G subclass-specific responses against Plasmodium falciparum Merozoite antigens are associated with control of parasitemia and protection from symptomatic illness. Infect. Immun. 2009, 77:1165-1174.
46. Suarez-mutis M.C., Cuervo P., Leoratti F.M., Moraes-Avila S.L., Ferreira A.W., Fernandes O., Coura J.R. Cross sectional study reveals a high percentage of asymptomatic Plasmodium vivax infection in the Amazon Rio Negro area, Brazil. Rev. Inst. Med. Trop. Sao Paulo 2007, 49:159-164.
47. Takala S.L., Smith D.L., Stine O.C., Coulibaly D., Thera M.A., Doumbo O.K., Plowe C.V. A high-throughput method for quantifying alleles and haplotypes of the malaria vaccine candidate Plasmodium falciparum merozoite surface protein-1 19kDa. Malar. J. 2006, 5:31.
48. Torres K.J., Clark E.H., Hernandez J.N., Soto-Cornejo K.E., Gamboa D., Branch O.H. Antibody response dynamics to the Plasmodium falciparum conserved vaccine candidate antigen, merozoite surface protein-1 C-terminal 19kDa (MSP1-19kDa), in Peruvians exposed to hypoendemic malaria transmission. Malar. J. 2008, 7:173.
49. Udhayakumar V., Anyona D., Kariuki S., Shi Y.P., Bloland P.B., Branch O.H., Weiss W., Nahlen B.L., Kaslow D.C., Lal A.A. Identification of T and B cell epitopes recognized by human in the C-terminal 42-kDa domain of the Plasmodium falciparum merozoite surface protein (MSP)-1. J. Immunol. 1995, 154:6022-6030.
50. Wang L., Crouch L., Richie T.L., Nhan D.H., Coppel R.L. Naturally acquired antibody responses to the components of the Plasmodium falciparum merozoite surface protein 1 complex. Parasite Immunol. 2003, 25:403-412.
51. Zakeri S., Mehrizi A.A., Zoghi S., Djadid N.D. Non-variant specific antibody responses to the C-terminal region of merozoite surface protein-1 of Plasmodium falciparum (PfMSP-119 in Iranians exposed to unstable malaria transmission. Malar. J. 2010, 9:257.